Introduction: In 2023, 35,000 new cases of breast cancer were diagnosed, becoming the first type of tumour diagnosed in Spain. This tumour and its treatments generate important changes in the patient's quality of life. Alterations in the range of motion, pain and both physical and psychological disability are some of the effects that breast cancer generates in patients. Physical prehabilitation could be an opportunity to prevent some of these adverse effects.
Objective: The objective of this review was to analyse the changes in objective and subjective variables in patients with breast cancer who undergo prehabilitation compared to those who perform other interventions.
Material And Method: Eight databases were used for the bibliographic search of the present review. Following the selected inclusion and exclusion criteria, seven studies were analysed. The quality of these studies was assessed with the PEDro scale. The structural characteristics of the various articles were examined, as well as the objective (ROM and biomarker) and subjective study variables (pain, physical and mental recovery, quality of life and psychological aspects.
Results: A total of 1054 patients were analysed in the present review. All objective variables improved in the group that underwent physical prehabilitation. Subjective variables also improved in said group, although the improvement achieved in psychological aspects was not maintained over time.
Conclusion: Physical prehabilitation is an interesting strategy to generate changes in breast cancer patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00520-024-09122-w | DOI Listing |
East Mediterr Health J
December 2024
Department of Radiology, King Abdulaziz University, Jeddah, Saudi Arabia.
Pharm Dev Technol
January 2025
Department of Pharmacy, School of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian 116029, China.
In this paper, the pH-sensitive targeting functional material NGR-poly(2-ethyl-2-oxazoline)-cholesteryl methyl carbonate (NGR-PEtOz-CHMC, NPC) modified quercetin (QUE) liposomes (NPC-QUE-L) was constructed. The structure of NPC was confirmed by infrared spectroscopy (IR) and nuclear magnetic resonance hydrogen spectrum (H-NMR). Pharmacokinetic results showed that the accumulation of QUE in plasma of the NPC-QUE-L group was 1.
View Article and Find Full Text PDFJ Med Econ
January 2025
UNESCO-TWAS, The World Academy of Sciences, Trieste, Italy.
Aim: Dynamic cancer control is a current health system priority, yet methods for achieving it are lacking. This study aims to review the application of system dynamics modeling (SDM) on cancer control and evaluate the research quality.
Methods: Articles were searched in PubMed, Web of Science, and Scopus from the inception of the study to November 15th, 2023.
Int J Surg
January 2025
Computer Science and Technology, Harbin Institute of Technology (Shenzhen), Shenzhen, China.
Detection of biomarkers of breast cancer incurs additional costs and tissue burden. We propose a deep learning-based algorithm (BBMIL) to predict classical biomarkers, immunotherapy-associated gene signatures, and prognosis-associated subtypes directly from hematoxylin and eosin stained histopathology images. BBMIL showed the best performance among comparative algorithms on the prediction of classical biomarkers, immunotherapy related gene signatures, and subtypes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!